BOULEAU PUBESCENT MACERAT GLYCERINE
Food supplement declared in France, declaration No 2024-2-661, decision dated 12 February 2024
BOULEAU PUBESCENT MACERAT GLYCERINE (Laboratoire Santarel) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Betula pubescens 0.45 ml per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Laboratoire Santarel
- Food business operator placing the product on the market
- PBO
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 15 gouttes
- Directions for use
- Prendre 5 gouttes 3 fois par jour avec un verre d'eau
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Allergy to salicylate derivatives, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking anticoagulants, Children (under 6), Children (under 10)
Declaration 139032, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Betula pubescens Ehrh. | Bourgeon | Autre macérât | 0.45 ml |
Additives
E422
Other ingredients
Eau purifiée, Alcool
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Ne pas dépasser la dose journalière recommandée. Ce complément alimentaire ne se substitue pas à une alimentation variée et équilibrée et à un mode de vie sain. Tenir hors de la portée des jeunes enfants. A conserver au frais et à l'abri de la lumière. Réservé à l'adulte. Déconseillé aux femmes enceintes ou allaitantes, en cas de traitement anticoagulant ou d'allergie aux dérivés salicylés et d'intolérance aux anti-inflammatoires non stéroïdiens.
Regulatory points
- Conditions légales
Betula pubescens Ehrh.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Betula pubescens Ehrh.
Read the warning, when it applies and the studies cited
Birch
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).
Sources cited by Health Canada (4)
- Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Laboratoire Santarel
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “BOULEAU PUBESCENT MACERAT GLYCERINE (Laboratoire Santarel): composition and regulation”, https://compoatlas.com/en/supplements/products/139032-bouleau-pubescent-macerat-glycerine, updated 15 November 2026.